Investment managers love bets made by both billionaire activists, according to a new analysis of top hedge fund stock positions.» Read More
Next week is an eclectic one for earnings. Here's what to expect from the retailers.
U.S. stock index futures were narrowly mixed Friday as investors hesitated to jump in as finance ministers and central banks from the Group of 20 met in Moscow amid growing worries over a currency war.
Carl Icahn now has a 13 percent stake in Herbalife. How great will Icahn's Herbalife gain be compared to Bill Ackman's Herbalife pain? Or will the tables turn? CNBC's David Faber, Carl Quintanilla and Melissa Lee discuss.
Hedge fund manager Bill Ackman, who made a $1 billion bet against the stock, told CNBC he remains convinced "Herbalife is a pyramid scheme," despite Carl Icahn stake.
Some of the names on the move ahead of the open.
Bill Ackman says he's concluded with certainty that Herbalife is a pyramid scheme. To the extent Carl Icahn is shining a light on the company, we "welcome his involvement," says Ackman of Icahn's new position in Herbalife. CNBC's Scott Wapner reports.
Here's the "Fast Money" Final Trade. Tomorrow's best trades, right now.
Carl Icahn bought 14 million shares of Herbalife, making a major bet against Pershing Square's Bill Ackman, who is short the stock. The two had an epic showdown on CNBC last month .
Carl Icahn bought 14 million shares of Herbalife, according to a 13-D filing with the Securities and Exchange Commission.
Discussing Carl Icahn's stake in Herbalife, and how he might trade the stock, with Ken Squire, 13D Management founder.
Check out which companies are making headlines after the bell Thursday:
Hedge fund manager William Ackman, who has called nutritional supplements company Herbalife a pyramid scheme, said the biggest risk in shorting the company was whether regulators would take time to focus on the matter.
Hedge fund titan Bill Ackman said the biggest risk in shorting Herbalife was whether regulators would notice.
Activist investor Bill Ackman is set to give tonight's keynote address at this year's Harbor Investment Conference, with CNBC's Kate Kelly.
Shares of the nutritional-supplement company are down 20% since the hedge-fund managers duked it out on CNBC on Jan 25.
In many ways, the fight over Herbalife boils down to one question: How many users of the company's product actually exist?
Stocks kicked off the week with sharp losses, with all three major averages posting their worst one-day performance this year, amid renewed worries over Europe and as investors took a breather after the Dow topped 14,000 for the first time since October 2007 last week.
Herbalife's stock is way too volatile for the faint of heart.
Herbalife shares plunged Monday after a newspaper reported the seller of weight loss products is facing a law enforcement probe, which the company denied.